Transformation to Lung Adenocarcinoma From Complete Remission-Experienced SCLC

J Thorac Oncol. 2020 Jan;15(1):e1-e3. doi: 10.1016/j.jtho.2019.07.035.

Authors

Zhongyu Wang¹, Qingzhu Jia¹, Xuefeng Tang², Lvjun Yan¹, Bo Zhu³

Affiliations

¹ Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
² Department of Pathology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
³ Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, China. Electronic address: b.davis.zhu@gmail.com.

PMID: 31864552
DOI: 10.1016/j.jtho.2019.07.035

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adenocarcinoma of Lung / drug therapy
Humans
Lung Neoplasms* / drug therapy
Small Cell Lung Carcinoma* / drug therapy